I

    Inogen Inc (INGN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $5.50
    -0.01 (-0.18%)

    Market Cap: $145.96M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    78%(31/40)
    Avg Surprise
    +45.17%
    Streak
    10 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.06
    Range$-0.06 - $-0.06
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.01+116.7%
    Current$-0.06
    Revenue Consensus
    $92M
    Range$92M - $93M
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.05
    Range$0.05 - $0.05
    1 analysts
    Revenue Consensus
    $87M
    Range$85M - $88M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.05---
    Sep 26EST
    		-$-0.06---
    Jun 26
    		$-0.14$-0.17+17.65%Beat+6.7%
    Mar 26
    		$-0.14$-0.21+33.33%Beat-27.3%
    Dec 25
    		$-0.15N/A+56.19%Beat+37.5%
    Sep 25
    		$-0.20$-0.22+9.09%Beat-81.8%
    Jun 25
    		$-0.15$-0.22+31.82%Beat-114.3%
    Mar 25
    		$-0.11N/A+56.00%Beat+75.6%
    Dec 24
    		$-0.24N/A+51.02%Beat+78.9%
    Sep 24
    		$-0.11N/A+59.26%Beat+69.4%
    Jun 24
    		$-0.07N/A+82.05%Beat+82.5%
    Mar 24
    		$-0.45$-0.58+22.41%Beat+42.3%
    Dec 23
    		$-1.14$-0.62-83.87%Miss-470.0%
    Sep 23
    		$-0.36$-0.23-56.52%Miss+14.3%
    Jun 23
    		$-0.40$-0.60+33.33%Beat-166.7%
    Mar 23
    		$-0.78$-0.75-4.00%Miss-25.8%
    Dec 22
    		$-0.20N/A+64.91%Beat+80.2%
    Sep 22
    		$-0.42$-0.38-10.53%Miss-179.2%
    Jun 22
    		$-0.15N/A+54.55%Beat-168.2%
    Mar 22
    		$-0.62$-0.51-21.57%Miss-1966.7%
    Dec 21
    		$-1.01$-0.73-38.36%Miss-339.1%
    Sep 21
    		$0.53$-0.29+282.76%Beat+762.5%
    Jun 21
    		$0.22$-0.10+320.00%Beat+83.3%
    Mar 21
    		$-0.03N/A+88.46%Beat+57.1%
    Dec 20
    		$-0.23$-0.26+11.54%Beat-283.3%
    Sep 20
    		$-0.08$-0.09+11.11%Beat-125.8%
    Jun 20
    		$0.12$-0.06+300.00%Beat-73.3%
    Mar 20
    		$-0.07$-0.11+36.36%Beat-129.2%
    Dec 19
    		$-0.06$0.10-160.00%Miss-113.6%
    Sep 19
    		$0.31$0.22+40.91%Beat-57.5%
    Jun 19
    		$0.45$0.49-8.16%Miss-30.8%
    Mar 19
    		$0.24$0.33-27.27%Miss-50.0%
    Dec 18
    		$0.44$0.25+76.00%Beat+41.9%
    Sep 18
    		$0.73$0.53+37.74%Beat+121.2%
    Jun 18
    		$0.65$0.44+47.73%Beat+71.1%
    Mar 18
    		$0.48$0.29+65.52%Beat+77.8%
    Dec 17
    		$0.31$0.23+34.78%Beat+24.0%
    Sep 17
    		$0.33$0.29+13.79%Beat+106.3%
    Jun 17
    		$0.38$0.28+35.71%Beat-
    Mar 17
    		$0.27$0.14+92.86%Beat-
    Dec 16
    		$0.25$0.11+127.27%Beat-
    Sep 16
    		$0.16$0.13+23.08%Beat-

    Key Metrics

    Valuation
    P/E Ratio-8.73EV/EBITDA-17.60x
    Price/FCF-29.85xFCF Yield-3.35%
    Profitability
    Profit Margin-6.94%Operating Margin-5.13%
    ROE-13.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio2.74xQuick Ratio2.34x
    Trading Statistics
    Beta1.60Avg Volume253.35K
    52-Week High$9.1352-Week Low$5.34

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.58
    SMA 20$5.89
    SMA 50$6.27
    SMA 200$6.43
    EMA 10$5.62
    EMA 20$5.81
    EMA 50$6.11
    EMA 200$6.53

    MACD

    Line: -0.24Signal: -0.22Hist: -0.02

    ADX

    ADX: 38.3+DI: 10.9-DI: 30.3

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down92.0
    PSAR$6.24

    Bollinger Bands

    Upper Band$6.76
    Lower Band$5.02
    %B Position2964%(Upper)
    Band Width0.28

    RSI (14-Day)

    Neutral
    31.8

    Momentum Oscillators

    Stoch %K8.4
    Stoch %D7.5
    Williams %R-94.3
    ROC (10d)-4.3%
    Momentum-0.25
    CCI (20d)-72.5
    MFI (14d)19.1

    Volatility Measures

    ATR (14d)$0.21(3.7%)
    StdDev (20d)0.44
    Hist Vol38.1%(Moderate)

    Volume Flow

    VWAP$5.54
    OBV-1.3M
    AD Line-3.5M
    CMF (20d)-0.325

    Volume Metrics

    Avg Vol (20d)258.3K
    Vol Ratio0.8x
    VWMA (20d)$5.95

    Pivot Points

    R3$5.67
    R2$5.64
    R1$5.57
    Pivot Point$5.54
    S1$5.47
    S2$5.44
    S3$5.37

    Advanced Oscillators

    TSI-31.99
    Ultimate Osc27.9
    KST-130.39

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$95.08M$85.11M$81.72M$92.39M$92.28M$82.28M$80.08M$88.83M$88.77M$78.03M$75.90M$83.97M
    Cost of Revenue$51.81M$47.25M$46.48M$51.07M$50.94M$45.91M$43.79M$47.49M$46.03M$43.65M$47.74M$50.20M
    Gross Profit$43.27M$37.86M$35.24M$41.32M$41.34M$36.37M$36.29M$41.34M$42.74M$34.37M$28.16M$33.76M
    Operating Expenses$48.37M$47.20M$44.54M$48.43M$47.47M$44.03M$47.67M$49.14M$49.80M$50.65M$57.14M$80.48M
    R&D$5.87M$5.10M$5.32M$4.84M$5.21M$4.03M$5.90M$3.52M$5.62M$6.58M$6.71M$4.49M
    SG&A$17.67M$17.50M$16.12M$18.15M$16.87M$16.24M$17.62M$19.26M$18.57M$17.13M$24.77M$17.01M
    Operating Income$-5,096,000$-9,336,000$-9,306,000$-7,116,000$-6,129,000$-7,656,000$-11,386,000$-7,792,000$-7,064,000$-16,274,000$-28,982,000$-46,721,000
    Interest Income$861,000$880,000$1.16M$1.07M$1.12M$1.03M$1.41M$1.04M$1.33M$1.40M$1.60M$1.80M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-4,004,000$-8,498,000$-7,363,000$-5,440,000$-4,305,000$-6,271,000$-10,087,000$-6,064,000$-5,597,000$-14,728,000$-27,088,000$-45,318,000
    Income Tax Expense$-154,000$-174,000$-236,000$-146,000$-153,000$-97,000$-330,000$-101,000$-7,000$-150,000$-533,000$401,000
    Net Income$-3,850,000$-8,324,000$-7,127,000$-5,294,000$-4,152,000$-6,174,000$-9,757,000$-5,963,000$-5,590,000$-14,578,000$-26,555,000$-45,719,000
    EBITDA$-168,000$-4,474,000$-3,491,000$-1,291,000$-212,000$-2,111,000$-6,420,000$-1,791,000$-1,585,000$-10,866,000$-23,546,000$-42,505,000
    EBIT$-4,865,000$-9,378,000$-8,526,000$-6,510,000$-5,428,000$-7,300,000$-11,500,000$-7,105,000$-6,930,000$-16,131,000$-28,690,000$-47,119,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INGN

    Government Contracts

    Gov Obligations (TTM)
    $23494
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    N/A

    Top agency: Department of Justice at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    15B10925P00000187Department of JusticeFederal Prison System / Bureau of Prisons$23494Sep 3, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Here's Why You Should Retain Inogen Stock in Your Portfolio for Now

    Inogen, Inc. (INGN) is positioned for growth due to strong demand for portable oxygen concentrators (POCs), an expanding B2B market, and international expansion. Despite these positive indicators, the company faces risks such as U.S. revenue pressure from channel shifts, volatility due to international distributor inventory timing, and clinical/reimbursement challenges for its Simeox technology. Inogen's valuation appears attractive with a P/S ratio of 0.4 compared to the industry's 2.7, and analysts project continued business improvements.

    TradingView•8/21/26•
    Somewhat-Bullish

    Top 3 Health Care Stocks That Could Blast Off This Month

    This article identifies three oversold healthcare stocks—Veracyte Inc (VCYT), Akso Health Group (AHG), and Inogen Inc (INGN)—that could present buying opportunities. These companies have a Relative Strength Index (RSI) near or below 30, indicating they may be undervalued. Recent news affecting each company, including earnings and R&D initiatives, are highlighted.

    Sahm•8/20/26•
    Somewhat-Bullish

    CPAP Store USA Adds New Inogen Aurora CPAP Mask Line

    CPAP Store USA has launched Inogen's new Aurora CPAP Mask Collection, becoming the first authorized online and in-store retailer for these non-magnetic masks. This expansion introduces three mask interfaces—F1 Full Face, N1 Nasal, and P1 Nasal Pillows—offering greater choice and comfort for CPAP and BiPAP users. The move signifies a notable expansion for both companies, with Inogen entering sleep therapy and CPAP Store USA broadening its respiratory care offerings.

    Sleep Review•8/19/26•
    Bullish

    Dimensional Fund Advisors LP Reduces Position in Inogen, Inc $INGN

    Dimensional Fund Advisors LP significantly reduced its stake in Inogen, Inc. by 28.3% in the first quarter, selling over 200,000 shares but still retaining a substantial holding. Despite this reduction, other institutional investors have increased their positions, and Inogen's stock holds a "Moderate Buy" consensus rating from analysts, even after a reiterated "sell" rating from Weiss Ratings. The company recently reported a narrower-than-expected quarterly loss, though revenue slightly missed forecasts, with analysts anticipating a full-year loss of $0.77 per share.

    MarketBeat•8/13/26•
    Somewhat-Bearish

    Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists

    Inogen, Inc. (INGN) has lowered its 2026 revenue outlook due to persistent U.S. channel pressure, specifically a decline in direct sales and rentals, despite strong international growth and improved profitability. The company expects 2026 revenues to be between $355 million and $361 million, a reduction from previous estimates. Inogen is focusing on business-to-business efforts and new products like the Voxi stationary oxygen concentrator to adapt to the changing market.

    Yahoo Finance Australia•8/11/26•
    Bearish

    Frequently Asked Questions About INGN

    Does INGN pay dividends?
    Inogen Inc (INGN) does not currently pay a regular dividend.
    What is INGN's market cap?
    Inogen Inc (INGN) has a market capitalization of $145.96M with a current stock price of $5.50.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In